Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.

Exp Mol Med 2017 08 11;49(8):e365. Epub 2017 Aug 11.

Department of Biochemistry, Ajou University School of Medicine, Suwon, Korea.

The proteasome inhibitor, bortezomib, is ineffective against many solid tumors. Nutlin-3 is a potent antagonist of human homolog of murine double minute 2/p53 interaction exhibiting promising therapeutic anti-cancer activity. In this study, we show that treatment of various p53-defective bortezomib-resistant solid tumor cells with bortezomib plus nutlin-3 induces paraptosis, which is a cell death mode accompanied by dilation of the endoplasmic reticulum (ER) and mitochondria. Bortezomib alone did not markedly alter cellular morphology, and nutlin-3 alone induced only a transient mitochondrial dilation. However, bortezomib/nutlin-3 co-treatment triggered the progressive fusion of swollen ER and the formation of megamitochondria, leading to cell death. Mechanistically, proteasomal-impairment-induced ER stress, CHOP upregulation and disruption of Ca homeostasis were found to be critically involved in the bortezomib/nutlin-3-induced dilation of the ER. Our results further suggest that mitochondrial unfolded protein stress may play an important role in the mitochondrial dilation observed during bortezomib/nutlin-3-induced cell death. Collectively, these findings suggest that bortezomib/nutlin-3 perturbs proteostasis, triggering ER/mitochondria stress and irrecoverable impairments in their structure and function, ultimately leading to paraptotic cell death.

Download full-text PDF

Source
http://dx.doi.org/10.1038/emm.2017.112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579507PMC
August 2017
12 Reads

Publication Analysis

Top Keywords

cell death
16
mitochondrial dilation
8
dilation observed
4
endoplasmic reticulum
4
observed bortezomib/nutlin-3-induced
4
bortezomib/nutlin-3-induced cell
4
dilation endoplasmic
4
reticulum mitochondria
4
bortezomib markedly
4
alter cellular
4
play role
4
nutlin-3
4
markedly alter
4
accompanied dilation
4
role mitochondrial
4
mitochondria bortezomib
4
dilation
4
cells bortezomib
4
nutlin-3 induces
4
tumor cells
4

References

(Supplied by CrossRef)

RC Kane et al.
Clin Cancer Res 2006

RC Kane et al.
Clin Cancer Res 2007

AM Ruschak et al.
J Natl Cancer Inst 2011

A Dispenzieri et al.
Leukemia 2010

AJ Kale et al.
J Med Chem 2012

LT Vassilev et al.
Science 2004

LT Vassilev et al.
Trends Mol Med 2007

H Shen et al.
Curr Pharm Des 2011

LM Lau et al.
Oncogene 2008

Y Tabe et al.
Clin Cancer Res 2009

S Supiot et al.
Mol Cancer Ther 2008

Similar Publications